Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKahraman, Seda
dc.contributor.authorErul, Enes
dc.contributor.authorGumusay, Ozge
dc.contributor.authorGuven, Deniz Can
dc.contributor.authorAksoy, Sercan
dc.contributor.authorBasaran, Gul
dc.contributor.authorSeyyar, Mustafa
dc.contributor.authorSahin, Elif
dc.contributor.authorCabuk, Devrim
dc.contributor.authorBayram, Ertugrul
dc.contributor.authorPaydas, Semra
dc.contributor.authorDemirel, Burcin Cakan
dc.contributor.authorYaren, Arzu
dc.contributor.authorGulbagci, Burcu
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorBaytemur, Naziyet Kose
dc.contributor.authorDemirci, Umut
dc.contributor.authorDavarci, Sena Ece
dc.contributor.authorDemir, Hacer
dc.contributor.authorMocan, Eda Eylemer
dc.contributor.authorDogan, Ozlem
dc.contributor.authorCilbir, Ebru
dc.contributor.authorYasar, Alper
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorHizal, Mutlu
dc.contributor.authorKayikcioglu, Erkan
dc.contributor.authorCetin, Bulent
dc.contributor.authorAcar, Omer
dc.contributor.authorErdogan, Atike Pinar
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorYilmaz, Funda
dc.contributor.authorDogan, Mutlu
dc.contributor.authorOrhan, Sibel Oyucu
dc.contributor.authorCubukcu, Erdem
dc.contributor.authorErol, Cihan
dc.contributor.authorSakalar, Teoman
dc.contributor.authorDulgar, Ozgecan
dc.contributor.authorKarakas, Yusuf
dc.contributor.authorOzkanli, Gulhan
dc.contributor.authorDuman, Berna Bozkurt
dc.contributor.authorIsik, Deniz
dc.contributor.authorKaraoglanoglu, Muge
dc.contributor.authorOkutur, Sadi Kerem
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorAydin, Esra
dc.contributor.authorUluc, Basak Oyan
dc.contributor.authorKeser, Murat
dc.contributor.authorBilgin, Burak
dc.contributor.authorAksoy, Asude
dc.contributor.authorEren, Onder
dc.contributor.authorKalkan, Nurhan Onal
dc.contributor.authorEr, Muhammed Muhiddin
dc.contributor.authorYucel, Hakan
dc.contributor.authorSunar, Veli
dc.contributor.authorPaksoy, Nail
dc.contributor.authorAydin, Dincer
dc.contributor.authorTurhal, Nazim Serdar
dc.contributor.authorMenekse, Serkan
dc.contributor.authorKut, Engin
dc.contributor.authorAykan, Musa Baris
dc.contributor.authorOzdemir, Ozlem
dc.contributor.authorOzcelik, Melike
dc.contributor.authorIriagac, Yakup
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorInal, Ali
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorAkinci, Muhammed Bulent
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.date.accessioned2025-10-16T15:11:41Z
dc.date.issued2025
dc.identifier.doi10.1016/j.clbc.2025.03.003
dc.identifier.otherWOS:001513877300025
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4926
dc.publisherCIG MEDIA GROUP, LP
dc.sourceCLINICAL BREAST CANCER
dc.subjectCDK 4
dc.subject6 inhibitors
dc.subjectFulvestrant
dc.subjectHR\\-positive
dc.subjectMetastatic breast cancer
dc.subjectReal\\-world data
dc.titleReal-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS